참고문헌
[1] Morgan, R., Preidis, G. A., Kashyap, P., Weizman, A., Sadeghirad, B., Chang, Y., Flórez, I., Foroutan, F., Shahid, S., & Zeraatkar, D. (2020). Probiotics Reduce Mortality and Morbidity in Preterm, Low-Birth-Weight Infants: A Systematic Review and Network Meta-analysis of Randomized Trials. Gastroenterology, 159, 467 - 480. https://doi.org/10.1053/j.gastro.2020.05.096
[2] Hughes, R. L., Alvarado, D., Swanson, K., & Holscher, H. (2021). The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review. Advances in Nutrition, 13, 492 - 529. https://doi.org/10.1093/advances/nmab119
[3] Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., Mohkam, M., Masoumi, S., Berenjian, A., & Ghasemi, Y. (2019). Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods, 8. https://doi.org/10.3390/foods8030092
[4] Ramírez, J., Guarner, F., Bustos Fernandez, L. B., Maruy, A., Sdepanian, V., & Cohen, H. (2020). Antibiotics as Major Disruptors of Gut Microbiota. Frontiers in Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.572912
[5] Pais, P., Almeida, V., Yilmaz, M., & Teixeira, M. C. (2020). Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?. Journal of Fungi, 6. https://doi.org/10.3390/jof6020078
[6] Waitzberg, D., Guarner, F., Hojsak, I., Ianiro, G., Polk, D., & Sokol, H. (2024). Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?. Advances in Therapy, 41, 901 - 914. https://doi.org/10.1007/s12325-024-02783-3